Failure of medicine supply
This risk concerns essential medicines, health products and vaccines, as a shortage of these products can have serious consequences.
A failure or shortage may result from:
- Supply problems: the healthcare system does not supply enough medical equipment to meet patients' needs;
- Demand problems: demand exceeds the capacity of the supply chain, ultimately leading to shortages.
Risks and causes
Causes
Consequences
What can you do?
- You can register with Pharmastatut to receive automatic e-mails when there are changes in the availability of a (group of) medicine(s).
- Ask your GP or pharmacist to discuss your treatment. Visit Pharmainfo.be to find out what you can do yourself (French/Dutch only)
Impact and probability
The figures relating to probability and impact describe a extreme failure in the supply of medicines. The BNRA theoretically describes such a scenario as follows:
- An interruption in the supply of medicines lasts more than a year and affects patients' vital care.
- No stocks or alternatives are available, which affects a large number of patients.
How should you interpret these results?
Within the BNRA, experts assessed three scenarios for each risk: considerable, major or extreme. On each page, you will find the results of the scenario with the highest score based on the combination of likelihood and impact. This does not mean that this scenario will occur or is the most likely. Read more here about how to correctly interpret the results.
Probability
Very weak
Human impact
Moderate
Societal impact
Weak
Environmental impact
No impact
Financial impact
Moderate
What do the authorities do?
The Federal Agency for Medicines and Health Products (FAMHP) oversees the supply of medicines in our country. Medicine manufacturers are required to notify the FAMHP if any of their medicines are unavailable.